Anteris Technologies GlobalvsJohnson & Johnson

AVR and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

AVR

Anteris Technologies Global Corp.

$4.99

Value $486M

-1.96%
AVR's page

Anteris Technologies Global (AVR) has a market value of $486M and Johnson & Johnson (JNJ) $652B. Over the last year, with dividends, AVR moved +46.8% and JNJ +36.6%. Dividend yield: AVR none, JNJ 1.95%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AVR$486M

    JNJ$652B

    JNJ is 1,340 times AVR

  • Revenue, 12 months

    AVR$2.3M

    JNJ$99.3B

    JNJ is 42,596 times AVR

  • Net income, 12 months

    AVR-$108M

    JNJ$16.1B

  • Operating margin

    AVR-4,880.4%

    JNJ–

  • ROIC

    AVR-59.0%

    JNJ12.4%

    71.4 points apart

  • P/E

    AVR–

    JNJ40.5

  • Dividend yield

    AVR0.0%

    JNJ2.0%

    2.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AVR+46.8%

JNJ+36.6%

100200300DecFebAprJunAugOct
Returns by period
PeriodAVRWith dividendsJNJWith dividends
1 year since November 19, 2025+46.8%Price +46.8%+36.6%Price +33.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AVRAnteris Technologies GlobalJNJJohnson & Johnson

Valuation

AVRJNJ
Valuation
Price$4.99$270.47
Market value$486M$652B
Enterprise value (EV)$270M$679B
P/E–40.5
P/E, 5-year median–21.9
P/B2.28.0
EV/EBIT–38.3
Free cash flow yield–3.2%

Results and growth

AVRJNJ
Results and growth
Revenue, 12 months$2.3M$99.3B
Net income, 12 months-$108M$16.1B
Free cash flow, 12 months-$93M$20.6B
Earnings per share, 12 months-$1.61$6.59
Revenue growth, year on year-29.2%6.1%
Revenue growth a year, past-29.2%over 1 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

AVRJNJ
Margins and returns on capital
Gross margin75.8%67.6%
Operating margin-4,880.4%–
Net margin-4,637.5%16.2%
ROIC-59.0%12.4%
ROE-71.1%19.7%

Balance sheet

AVRJNJ
Balance sheet
Cash$217M$17.2B
Total debt$16M$44.7B
Net debt / EBITDA–1.1
Interest cover-615.2×18.0×

Dividends and buybacks

AVRJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AVR or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Anteris Technologies Global or Johnson & Johnson?

By market value, Johnson & Johnson ($652B) is about 1,339.8 times Anteris Technologies Global ($486M), at today's prices.

How did AVR and JNJ stock do over the last 1 years?

Since November 19, 2025, AVR's price moved +46.8% and JNJ's +33.6%. With dividends: AVR +46.8% (+46.8% a year), JNJ +36.6% (+36.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, AVR or JNJ?

The dividend yield at today's price is none for Anteris Technologies Global and 1.95% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, Anteris Technologies Global or Johnson & Johnson?

Over the last twelve months, the net margin was -4,637.5% for Anteris Technologies Global and 16.2% for Johnson & Johnson, and the operating margin -4,880.4% and –. Revenue was $2.3M and $99.3B.

Which is the better investment, Anteris Technologies Global or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.